Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ODT - Odonate Therapeutics Inc

Previous close
1.12
0   0%

Share volume: 0
Last Updated: Fri 14 Jan 2022 06:00:00 AM CET
Medicinal and Botanical Manufacturing : -0.98%

PREVIOUS CLOSE
CHG
CHG%
$1.12
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
45%
Profitability 50%
Dept financing 19%
Liquidity 72%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$1.12
P/E Ratio 
0.00
DAY RANGE
$1.12 - $1.12
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
38.490 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website: www.odonate.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Medicinal and Botanical Manufacturing
Sector: Manufacturing

Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.

Recent news